<DOC>
	<DOCNO>NCT02464696</DOCNO>
	<brief_summary>The goal clinical research study learn whether use early non-invasive positive pressure ventilation ( NIPPV ) , method deliver oxygen use mask , high flow oxygen ( use tube 2 prong place nostril ) well improve amount oxygen blood , reduce shortness breath , need intubation ( placement tube windpipe ) patient blood cancer hypoxemia .</brief_summary>
	<brief_title>Early Non Invasive Ventilation Hematological Malignancies</brief_title>
	<detailed_description>Study Groups : If agree take part study , randomly assign ( flip coin ) 1 2 group . This do one know one study group well , , bad group . You equal chance either group : - If Group 1 , receive high flow oxygen nose . - If Group 2 , receive oxygen mask ( NIPPV ) . You also receive high flow oxygen nose , doctor think need ( describe ) . Study Procedures : Before begin treatment every 4 hour hospital , study staff visit . At time , brief physical exam . This include check well breathe , alert , measure oxygen level . These visit continue hypoxemia improves enough longer need frequent checking . If condition worsens Group 1 study doctor think best interest , allow receive oxygen NIPPV mask . If Group 2 condition improves want wear mask anymore , allow receive oxygen nose . The study staff follow progress review medical chart 28 day start study leave hospital ( whichever come first ) . During time , study staff may visit learn well tolerate treatment . Length Study : Your participation study 28 day leave hospital . Researchers continue collect information regard health medical record 100 day .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>1 . Age &gt; 18 year old 2 . PaO2 : FiO2 ratio &lt; 300 mmHg OR SpO2 : FiO2 &lt; 357 3 . Have diagnose hematological malignancy 1 . Presence DNR/DNI order study entry 2 . Clinical evidence leave heart failure main etiology respiratory compromise 3 . Evidence accessory respiratory muscle use respiration 4 . Shock ( need vasopressor therapy MAP &lt; 60 despite fluid administration ) 5 . Oliguric acute renal failure ( urine output &lt; 500 ml/day ) unless already hemodialysis 6 . Patient already NIPPV time screen 7 . Contraindications NIPPV therapy : ) pH &lt; 7.30 pCO2 &gt; 50 ( available ) b ) Fixed upper airway obstruction c ) Airway facial trauma would hinder use NIPPV mask ) Uncontrolled tachy bradyarrhythmia active myocardial ischemia define either : Atrial fibrillation rapid ventricular response ( HR &gt; 120 bpm ) , Ventricular tachycardia nonsustained ventricular tachycardia , Supraventricular tachycardia , Third degree heart block , heart rate le 40 bpm e ) Active myocardial ischemia ( acute ST elevation non ST elevation MI f ) GCS &lt; 8 inadequate airway protective reflex g ) Undrained pneumothorax/pneumomediastinum h ) Copious secretion ( &gt; 20cc/hr sputum production &gt; 100 cc 's hemoptysis/24 hr , ) Risk gastric aspiration ( ie ; ileus , esophageal bowel obstruction , active vomiting ) j ) Recent esophageal , gastric bowel surgery ( within 3 week study enrollment ) k ) Inability cooperate NIPPV l ) Refusal receive NIPPV ) Respiratory arrest</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Hematological Malignancies</keyword>
	<keyword>Hypoxemic Respiratory Failure</keyword>
	<keyword>Blood cancer</keyword>
	<keyword>Non-invasive positive pressure ventilation</keyword>
	<keyword>NIPPV</keyword>
	<keyword>High flow nasal cannula oxygen therapy</keyword>
</DOC>